H. Robin Heyman

826 total citations
20 papers, 575 citations indexed

About

H. Robin Heyman is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, H. Robin Heyman has authored 20 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in H. Robin Heyman's work include Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (4 papers) and Protein Degradation and Inhibitors (3 papers). H. Robin Heyman is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (4 papers) and Protein Degradation and Inhibitors (3 papers). H. Robin Heyman collaborates with scholars based in United States and United Kingdom. H. Robin Heyman's co-authors include Steven K. Davidsen, Michael L. Curtin, Patrick A. Marcotte, Daniel H. Albert, Robert B. Garland, Robin R. Frey, Lori J. Pease, Keith B. Glaser, James B. Summers and James H. Holms and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

H. Robin Heyman

20 papers receiving 554 citations

Peers

Countries citing papers authored by H. Robin Heyman

Since Specialization

Citations

This map shows the geographic impact of H. Robin Heyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Robin Heyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Robin Heyman more than expected).

Fields of papers citing papers by H. Robin Heyman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Robin Heyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Robin Heyman. The network helps show where H. Robin Heyman may publish in the future.

Co-authorship network of co-authors of H. Robin Heyman

This figure shows the co-authorship network connecting the top 25 collaborators of H. Robin Heyman. A scholar is included among the top collaborators of H. Robin Heyman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Robin Heyman. H. Robin Heyman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitors 2020 ·Bioorganic & Medicinal Chemistry Letters ·John T. Randolph, Tongmei Li, A. Chris Krueger, H. Robin Heyman, Hui-Ju Chen, Daniel A.J. Bow, (unknown), Vincent Peterkin, Robert A. Carr, DeAnne Stolarik, Tatyana Dekhtyar, Michelle Irvin, Preethi Krishnan, Rolf Wagner, David A. DeGoey	3
2	Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families 2012 ·Bioorganic & Medicinal Chemistry Letters ·Michael L. Curtin, Robin R. Frey, H. Robin Heyman, Niru B. Soni, Patrick A. Marcotte, Lori J. Pease, Keith B. Glaser, Terrance J. Magoc, Paul Tapang, Daniel H. Albert, Donald J. Osterling, Amanda M. Olson, Jennifer J. Bouska, Zhiwen Guan, Lee C. Preusser, James S. Polakowski, Kent D. Stewart, Chris Tse, Steven K. Davidsen, Michael R. Michaelides	19
3	Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases 2012 ·Bioorganic & Medicinal Chemistry Letters ·Michael L. Curtin, H. Robin Heyman, Robin R. Frey, Patrick A. Marcotte, Keith B. Glaser, (unknown), Terrance J. Magoc, Daniel H. Albert, Amanda M. Olson, David R. Reuter, Jennifer J. Bouska, Debra Montgomery, Joann P. Palma, Cherrie K. Donawho, Kent D. Stewart, Chris Tse, Michael R. Michaelides	12
4	Thienopyridine urea inhibitors of KDR kinase 2006 ·Bioorganic & Medicinal Chemistry Letters ·H. Robin Heyman, Robin R. Frey, Peter F. Bousquet, George A. Cunha, Maria D. Moskey, Asma A. Ahmed, Niru B. Soni, Patrick A. Marcotte, Lori J. Pease, Keith B. Glaser, Melinda S. Yates, Jennifer J. Bouska, Daniel H. Albert, (unknown), Peter J. Dandliker, Kent D. Stewart, Paul Rafferty, Steven K. Davidsen, Michael R. Michaelides, Michael L. Curtin	33
5	Differential protein acetylation induced by novel histone deacetylase inhibitors 2004 ·Biochemical and Biophysical Research Communications ·Keith B. Glaser, (unknown), Lori J. Pease, Michael J. Staver, Patrick A. Marcotte, Jun Guo, Robin R. Frey, Robert B. Garland, H. Robin Heyman, Carol K. Wada, Anil Vasudevan, (unknown), Steven K. Davidsen, Michael L. Curtin	51
6	Isoindolinone ureas: a novel class of KDR kinase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Michael L. Curtin, Robin R. Frey, H. Robin Heyman, Kathy Sarris, Douglas H. Steinman, James H. Holmes, Peter F. Bousquet, George A. Cunha, Maria D. Moskey, Asma A. Ahmed, Lori J. Pease, Keith B. Glaser, Kent D. Stewart, Steven K. Davidsen, Michael R. Michaelides	26
7	Heterocyclic ketones as inhibitors of histone deacetylase 2003 ·Bioorganic & Medicinal Chemistry Letters ·Anil Vasudevan, Zhiqin Ji, Robin R. Frey, Carol K. Wada, Douglas H. Steinman, H. Robin Heyman, Yan Guo, Michael L. Curtin, Jun Guo, Junling Li, Lori J. Pease, Keith B. Glaser, Patrick A. Marcotte, Jennifer J. Bouska, Steven K. Davidsen, Michael R. Michaelides	33
8	Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC) 2002 ·Bioorganic & Medicinal Chemistry Letters ·Michael L. Curtin, Robert B. Garland, H. Robin Heyman, Robin R. Frey, Michael R. Michaelides, Junling Li, Lori J. Pease, Keith B. Glaser, Patrick A. Marcotte, Steven K. Davidsen	97
9	Biaryl Ether Retrohydroxamates as Potent, Long-lived, Orally Bioavailable MMP Inhibitors 2001 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Joseph F. Dellaria, (unknown), James H. Holms, Jennifer J. Bouska, (unknown), Carol K. Wada, H. Robin Heyman, Michael L. Curtin, Yan Guo, (unknown), (unknown), Daniel H. Albert, Terrance J. Magoc, Patrick A. Marcotte, Douglas W. Morgan, Steven K. Davidsen	43
10	Phenoxyphenyl SulfoneN-Formylhydroxylamines (Retrohydroxamates) as Potent, Selective, Orally Bioavailable Matrix Metalloproteinase Inhibitors 2001 ·Journal of Medicinal Chemistry ·Carol K. Wada, James H. Holms, Michael L. Curtin, Yujia Dai, Alan S. Florjancic, Robert B. Garland, Yan Guo, H. Robin Heyman, (unknown), Douglas H. Steinman, Daniel H. Albert, Jennifer J. Bouska, (unknown), (unknown), Patrick A. Marcotte, Paul Tapang, Douglas W. Morgan, (unknown), Steven K. Davidsen	81
11	Evaluation of the Inhibition of other Metalloproteinases by Matrix Metalloproteinase Inhibitors 1999 ·Journal of enzyme inhibition ·Patrick A. Marcotte, (unknown), Zhiwen Guan, Terrance J. Magoc, Daniel H. Albert, Douglas W. Morgan, Michael L. Curtin, Robert B. Garland, Yan Guo, H. Robin Heyman, James H. Holms, George S. Sheppard, Douglas H. Steinman, Carol K. Wada, Steven K. Davidsen	6
12	The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·Douglas H. Steinman, Michael L. Curtin, Robert B. Garland, Steven K. Davidsen, H. Robin Heyman, James H. Holms, Daniel H. Albert, (unknown), (unknown), Patrick A. Marcotte, Junling Li, Douglas W. Morgan, Charles W. Hutchins, James B. Summers	26
13	Discovery and Evaluation of a Series of 3-Acylindole Imidazopyridine Platelet-Activating Factor Antagonists 1998 ·Journal of Medicinal Chemistry ·Michael L. Curtin, Steven K. Davidsen, H. Robin Heyman, Robert B. Garland, George S. Sheppard, Alan S. Florjancic, Lianhong Xu, George M. Carrera, Douglas H. Steinman, (unknown), Daniel H. Albert, Terrance J. Magoc, Paul Tapang, (unknown), Richard G. Conway, (unknown), Jon F. Denissen, Kennan C. Marsh, Douglas W. Morgan, James B. Summers	27
14	Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist 1997 ·European Journal of Pharmacology ·Daniel H. Albert, Terrance J. Magoc, Paul Tapang, (unknown), Douglas W. Morgan, Michael L. Curtin, George S. Sheppard, Lianhong Xu, H. Robin Heyman, Steven K. Davidsen, James B. Summers, George W. Carter	25
15	Synthesis and evaluation of water soluble indole pyrrolothiazole paf antagonists 1995 ·Bioorganic & Medicinal Chemistry Letters ·George S. Sheppard, Steven K. Davidsen, George M. Carrera, Daisy Pireh, James H. Holms, H. Robin Heyman, Douglas H. Steinman, Michael L. Curtin, Richard G. Conway, (unknown), Daniel H. Albert, Paul Tapang, Terrance J. Magoc, James B. Summers	3
16	Discovery and optimization of indole pyrrolothiazole paf antagonists 1995 ·Bioorganic & Medicinal Chemistry Letters ·James H. Holms, Steven K. Davidsen, George S. Sheppard, George M. Carrera, (unknown), H. Robin Heyman, Daisy Pireh, Douglas H. Steinman, Daniel H. Albert, Richard G. Conway, (unknown), Terrance J. Magoc, Paul Tapang, (unknown), James B. Summers	2
17	N-(Acyloxyalkyl)pyridinium Salts as Soluble Prodrugs of a Potent Platelet Activating Factor Antagonist 1994 ·Journal of Medicinal Chemistry ·(unknown), James B. Summers, Daniel H. Albert, James H. Holms, H. Robin Heyman, Terrance J. Magoc, Richard G. Conway, (unknown), George W. Carter	39
18	3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a Novel Series of Platelet Activating Factor Antagonists 1994 ·Journal of Medicinal Chemistry ·George S. Sheppard, Daisy Pireh, George M. Carrera, Mark G. Bures, H. Robin Heyman, Douglas H. Steinman, (unknown), James G. Phillips, (unknown), Paul D. May, (unknown), (unknown), (unknown), Daniel H. Albert, Terrance J. Magoc, George W. Carter, James B. Summers	23
19	Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonists 1992 ·Journal of Medicinal Chemistry ·(unknown), James B. Summers, H. Robin Heyman, Richard G. Conway, (unknown), Daniel H. Albert, (unknown), George W. Carter	19
20	Chemical synthesis and surface activity of lung surfactant phospholipid analogs. III. Chiral N-substituted ether-amide phosphonolipids 1991 ·Chemistry and Physics of Lipids ·Joseph G. Turcotte, (unknown), (unknown), (unknown), (unknown), H. Robin Heyman, Shyam Shirali, (unknown), Robert H. Notter	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact